137 related articles for article (PubMed ID: 14695324)
1. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice.
Curfs DM; Lutgens E; Gijbels MJ; Kockx MM; Daemen MJ; van Schooten FJ
Am J Pathol; 2004 Jan; 164(1):101-8. PubMed ID: 14695324
[TBL] [Abstract][Full Text] [Related]
2. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties.
Curfs DM; Knaapen AM; Pachen DM; Gijbels MJ; Lutgens E; Smook ML; Kockx MM; Daemen MJ; van Schooten FJ
FASEB J; 2005 Aug; 19(10):1290-2. PubMed ID: 15939734
[TBL] [Abstract][Full Text] [Related]
3. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models.
Curfs DM; Beckers L; Godschalk RW; Gijbels MJ; van Schooten FJ
Environ Mol Mutagen; 2003; 42(4):243-9. PubMed ID: 14673869
[TBL] [Abstract][Full Text] [Related]
4. The environmental carcinogen benzo[a]pyrene induces expression of monocyte-chemoattractant protein-1 in vascular tissue: a possible role in atherogenesis.
Knaapen AM; Curfs DM; Pachen DM; Gottschalk RW; de Winther MP; Daemen MJ; Van Schooten FJ
Mutat Res; 2007 Aug; 621(1-2):31-41. PubMed ID: 17376491
[TBL] [Abstract][Full Text] [Related]
5. Benzo[a]pyrene enhances lipid peroxidation induced DNA damage in aorta of apolipoprotein E knockout mice.
Godschalk R; Curfs D; Bartsch H; Van Schooten FJ; Nair J
Free Radic Res; 2003 Dec; 37(12):1299-305. PubMed ID: 14753754
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
Godschalk RW; Albrecht C; Curfs DM; Schins RP; Bartsch H; van Schooten FJ; Nair J
Mutat Res; 2007 Aug; 621(1-2):87-94. PubMed ID: 17418875
[TBL] [Abstract][Full Text] [Related]
7. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
[TBL] [Abstract][Full Text] [Related]
8. Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta.
Uno S; Sakurai K; Nebert DW; Makishima M
Toxicology; 2014 Feb; 316():34-42. PubMed ID: 24394547
[TBL] [Abstract][Full Text] [Related]
9. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
11. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.
Bot I; von der Thüsen JH; Donners MM; Lucas A; Fekkes ML; de Jager SC; Kuiper J; Daemen MJ; van Berkel TJ; Heeneman S; Biessen EA
Circ Res; 2003 Sep; 93(5):464-71. PubMed ID: 12919945
[TBL] [Abstract][Full Text] [Related]
12. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.
Afek A; Harats D; Roth A; Keren G; George J
Exp Mol Pathol; 2004 Jun; 76(3):219-23. PubMed ID: 15126104
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
[TBL] [Abstract][Full Text] [Related]
15. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo.
Guevara NV; Kim HS; Antonova EI; Chan L
Nat Med; 1999 Mar; 5(3):335-9. PubMed ID: 10086392
[TBL] [Abstract][Full Text] [Related]
16. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.
Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M
J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.
Xu S; Little PJ; Lan T; Huang Y; Le K; Wu X; Shen X; Huang H; Cai Y; Tang F; Wang H; Liu P
Arch Biochem Biophys; 2011 Nov; 515(1-2):72-9. PubMed ID: 21889487
[TBL] [Abstract][Full Text] [Related]
19. Remodelling of the zero-stress state and residual strains in apoE-deficient mouse aorta.
Gregersen H; Zhao J; Lu X; Zhou J; Falk E
Biorheology; 2007; 44(2):75-89. PubMed ID: 17538200
[TBL] [Abstract][Full Text] [Related]
20. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
Davenport P; Tipping PG
Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
